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Abstract
Background: This pilot study investigated whether semi-rigid and soft orthoses had 
an effect on pain, disability and functional limitation in participants with chronic 
Rheumatoid hindfoot involvement. 
Methods: Participants with chronic hindfoot pain were randomly assigned to 2 
groups, commencing either with semi-rigid Subortholene orthoses or soft EVA 
orthoses. The Foot Function Index and the Ritchie Articular Index were administered 
pre- and post-intervention, which lasted for 3 months. Following a 2 week washout 
period, each group was switched over to the other type of orthoses. 
Results: Nine female participants (Mean age 52.2yrs (SD 9.1); mean weight 71kg 
(SD 12.64); mean height 160cm (SD 5.18)) with a mean RA duration of 11.7years 
(SD 7.83), and a mean ankle/subtalar joint pain duration of 5.7years (SD 2.62), 
completed the programme. Mean improvement in FFI score for both orthoses resulted 
in the same statistical significance (p=0.001). Statistically significant reduction in 
pain, disability and functional limitation was observed for both interventions, together 
with improvement in the Ritchie Articular Index score.
Conclusion: Both Subortholene and EVA orthoses significantly reduced pain, 
disability and functional limitations in participants with chronic ankle/subtalar joint 
pain in rheumatoid arthritis. 
Keywords: foot orthoses; hindfoot rheumatoid disease; chronic ankle arthritis; foot 
function index
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Introduction
Rheumatoid Arthritis (RA) is a chronic systemic disease affecting predominantly 
synovial joints, often resulting in their progressive destruction through joint erosion 
and subsequent deformity [1]. RA affects around 90% of afflicted sufferers’ feet, 
which have been found to be the most common reason for incapacity in patients with 
this disease [2], leaving a severe negative impact on mobility and functional capacity 
when this disease process begins to affect their feet [3]. Synovitis, with ingrowth of 
pannus and cytokines, causes destruction of joint cartilage that can lead to erosions 
[4] and resultant pain, which has a strong influence on functional ability [5].
In RA, involvement of the hindfoot has been quoted as being between 17% in a 
Swedish study [6] to 40% [7]. The resultant pain, functional loss and disability are 
difficult to manage [8], becoming in many instances significant sources of morbidity 
[9]. It appears likely that the subtalar and ankle joints are affected in the most severe 
form of the disease, with the sub alar joint being involved approximately 5 to 7 years 
prior to the talocrural joint [10]. The talus, a component common to both joints, is the 
single bone through which the whole body weight is channelled during walking 
(Laude, 2001). Abnormal alignment of the subtalar joint and mechanical stress have 
been attributed for many of the changes in the ankle in arthritis [11].
Patients living with RA need to be managed with drugs that carry potential risks of 
significant side effects in order to reduce joint destruction and consequent pain. 
However, in spite of the best medical management, significant foot problems persist, 
even when treated with biological therapies [12]. Unfortunately, besides drug therapy, 
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there are not many options for the management of painful ankles in RA except for 
surgical intervention. While arthrodesis reduces pain, it does not improve function
since the addressed joint is surgically locked. Furthermore, results can often be 
disappointing [9], besides possible complications such as infection and non-union 
[13].
In arthritis, orthoses are indicated for a variety of reasons such as resting and 
stabilization of joints, reduction of pain and inflammation, to improve function and 
prevent deformity [14], being nowadays more widely accepted [15].  However, even 
though orthoses are used quite extensively in the management of the rheumatoid foot, 
there are few trials which investigate directly their effect on the RA hindfoot. In fact, 
studies have concentrated more on forefoot-related conditions [16].  This could 
possibly be due to the inherent problems in studying the hindfoot. It is quite difficult 
to identify subjects purely with hindfoot disease, because the forefoot is normally 
affected first. In a critical review of foot orthoses in the rheumatoid arthritic foot, 
Clark et al [17]  argued that, although there is strong evidence that foot orthoses do 
reduce pain and improve functional ability, there is no consensus on the choice of foot 
orthoses used for the management of rheumatoid foot pathology, with types of 
orthoses ranging from rigid devices to simple cushioned insoles. Hennessy et al [18]
report weak evidence for custom orthoses reducing pain and forefoot plantar 
pressures, while evidence was inconclusive for foot function and other gait 
parameters. They concluded that although custom orthoses may be beneficial, more 
definitive research is required in this area.
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Foot orthoses can be assessed utilizing several methodologies, including patient 
satisfaction, pain and deformity, plantar pressure, position and motion, muscle 
activity and oxygen consumption [19]. Pain is used as a primary outcome measure in 
many such studies because it is the reason most patients seek treatment and for which 
practitioners prescribe orthoses [20]. The Foot Function Index (FFI) is indicated for 
the assessment of treatment outcomes in rheumatology [21] and has been used in a 
number of trials involving the assessment of orthoses in rheumatoid feet. SooHoo et 
al [22] performed a study which demonstrated increased responsiveness of foot and 
ankle specific outcomes tools compared to the SF-36. De P Magalhaes et al [23]
utilized the FFI to evaluate the effectiveness of foot orthoses in a group of patients 
with RA over a period of 6 months, concluding that foot orthoses were effective as an 
adjuvant in the management of the rheumatoid foot.
Woodburn, Barker and Helliwell [24] utilized the Foot Function Index and 3D 
kinematics, kinetics and plantar pressure distribution to establish that custom-
manufactured foot orthoses are indicated in early hindfoot deformity in RA. The 
orthoses lessened foot-related pain, disability and functional limitation. Cameron-
Fiddes concluded that patients diagnosed with early RA may beneﬁt from using off-
the-shelf foot orthoses with the majority of their pain reduction occurring within the 
ﬁrst 3 months of use [25]. However, following an extensive literature search, there is 
a clear paucity of information regarding trials aimed at investigating advanced
hindfoot disease. 
Subtalar and ankle joint alignment and stress are determinant factors in hindfoot 
disease. It is possible that the reduction of stress and possibly the realignment of these 
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joints, whenever possible, through the use of orthoses, would be beneficial in 
reducing pain, disability and functional limitation for the afflicted patients. Hence the 
aim of this study was to determine whether two types of orthoses - semi-rigid 
Subortholene and soft ethylene vinyl acetate (EVA) orthoses - are effective in 
reducing pain, disability and functional limitation in patients with chronic ankle joint 
complex involvement in RA. This study would additionally provide information about 
two types of orthoses that may be used for the management of the painful hindfoot in
RA.
Method
Ethical approval was sought and obtained from the University Ethics Committee. A 
prospective, experimental crossover design was employed for this study, in which two 
interventions (semi-rigid and soft Orthoses) were applied sequentially to the same 
participants in random order. This had the advantage that each participant acted as his 
own control, thus a smaller sample size would be required [26]. 
Adult participants (aged 18years and over) living with chronic Rheumatoid Arthritis 
diagnosed by a consultant rheumatologist were included. The chronicity factor was a 
common feature amongst participants since hindfoot involvement is known to occur 
in advanced disease. As inclusion criteria, all participants exhibited subtalar and/or 
ankle joint pain of at least 6 months’ duration and required orthoses for biomechanical 
mal-alignment of the feet as per clinical practice. Participants were also required to 
have the ability to read unhindered in order to be able to independently complete the 
presented questionnaire.
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Participants were excluded if they had foot pain other than subtalar/ankle pain, were
in a flare, had a change of treatment during the trial period, were unable to read, had a 
history of foot surgery or had trauma to the foot during the trial period. 
Twenty-one patients attending a Rheumatology Outpatient clinic at a General 
Hospital, medically confirmed to be suffering with RA and who presented with 
subtalar and/or ankle joint pain were identified as potential participants for the trial.
These were reduced to 10 because of the exclusion criteria adopted, the main criteria 
of which was that they only had to suffer from hindfoot pain without coexisting
forefoot involvement. Thus eleven patients were excluded mainly because they 
presented with such concurrent foot pain. 
Out of the remaining ten who started the trial, another participant had to be excluded 
half way through the trial because she developed a rheumatoid flare, for which she 
was prescribed steroid and Disease Modifying Anti-Rheumatic Drug Therapy, thus 
invalidating her as a participant. 
Casting
In order to ensure consistency, all the casts were taken and then modified by the same 
investigator (AG), who had fifteen years’ experience in this method of casting and 
orthotic manufacture. 
A standard plaster of Paris suspension cast was taken with the patient prone and the 
feet over the edge of the couch. Where necessary, a towel was placed under the hip on 
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the side of the foot which was being casted to ensure that the foot was maintained in a 
straight position by rotating it internally. The manufacture of the orthoses followed 
normal procedures as would be employed in the clinic. These were constructed 
following a detailed biomechanical examination in which the range of motion of 
the joints of the foot, most notably that of the subtalar joint, were assessed and 
measurements at Neutral Calcaneal Stance Position and Resting Calcaneal 
Stance Position determined the amount of rearfoot posting that was 
incorporated into the orthoses.
Since the majority of participants were in an advanced state of RA, with limited range 
of motion of the joints, a pronated cast was taken [27, 28]. This has often been quoted 
as being the best method for managing the arthritides since, if the foot is rigid, it is 
inappropriate to attempt to position it in any particular orientation [28].
Orthoses
All the orthoses were manufactured by the same person in order to ensure a standard 
device. The positive casts were modified as outlined by Philps [29].  Following the 
necessary positive model modifications, two different types of orthoses were 
manufactured simultan ously over the same cast for each participant. The materials 
utilized were 3mm Subortolene (Tuefel GmbH, Frankfurt, Germany) and low-density 
(Shore A25) Etylene Vinyl Acetate (EVA) (Algeos Ltd, Liverpool, UK).  For 
descriptive purposes, these interventions were termed Condition 1Subortolen and 
Condition 2EVA.
It had been determined beforehand to start five subjects with Condition 1Subortolen and 
the other five with Condition 2EVA to offset any carryover effect that might occur 
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during the trial.  The condition was assigned randomly to each subject using the raffle
method [30].
The orthoses were dispensed as per normal clinical practice.  Each participant was 
advised to start using the orthoses in appropriate footwear, initially just for two hours, 
and then to gradually increase wearing time each day until they could be worn 
comfortably for most of the day [29]. If for any reason there was a problem with 
fitting, the participant had to contact the investigator for any necessary minor 
adjustments.
Each intervention lasted for 3 months, with a two week period for washout in between
[20].  Thus, if a participant started with Condition 2EVA, she then continued with 
Condition 1Subortolen, and vice versa for the other participants (AB/BA).
At the start and end of each intervention, the Foot Function Index [31] and Ritchie
Articular Index (RAI) [32], were applied to each participant. Although the FFI is foot 
specific, it does not differentiate from pain in different areas of the foot - eg. forefoot 
from rearfoot pain.  Thus if a subject had pain located in any areas of the foot other 
those under observation, the FFI would not be able to make allowances for this and 
the results would not reflect the actual pain condition specifically for the hindfoot. 
Hence, particular attention was given to subject selection, ensuring that only subjects 
with hindfoot pain were included, so as not to invalidate the study. 
The RAI is used solely or in conjunction with other indexes to measure efficacy of 
treatments in RA by recording joint tenderness [32, 33]. When assessing the RAI for 
the ankle, the finger of the examining hand was placed between the extensor hallucis 
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longus and extensor digitorum longus tendons at the level of the malleoli, followed by 
the application of pressure until blanching underneath the nail of the investigator was 
observed (in order to apply a consistent amount of pressure as required by the RAI). 
For assessment of the subtalar joint, the ankle joint was fixed anteriorly with the 
supporting hand, then the index and middle fingers and thumb of the examining hand 
were placed on either side of the subtalar joint. This was then moved through 
inversion and eversion of the calcaneum by 5o to 10o, depending on the range of 
movement available at the joint [32].
The participants’ responses were then tabulated accordingly; with 0 for no pain, +1
for Tender, +2 for Tender and Winced and +3 for Tender, Winced and Withdrew           
[33]. 
An important aspect of the whole study design was the determination that no 
carryover effect was present, which would invalidate the results since one would not 
be able to determine which par  of the second result would be due to the second 
intervention itself and which part to attribute to the first intervention. To eliminate 
this possibility, a 2 we k washout period was implemented, as is normal practice in 
crossover designs.
Results
Nine female participants (mean age 52.2yrs (SD 9.1); mean weight 71 kg (SD 12.64); 
mean height 160cm (SD 5.18)) completed the whole programme. Participants had a 
mean RA duration of 11.7 years (SD 7.83), with a mean ankle/subtalar joint pain 
duration of 5.7years (SD 2.62). 
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Testing for carryover effect (defined as the possible effect from the first intervention 
on to the second intervention) was achieved by grouping the first pre-intervention 
scores together (i.e. 5 subortholen and 4 EVA) and the second pre-intervention scores 
together (i.e. 4 subortholen and 5 EVA), then testing with the One-Sample 
Kolmogrov-Smirnov Test, which revealed a normal distribution. Consequently a 
paired t-test was performed, which showed that there were no statistically significant 
differences between the two groups (p=0.726).
Statistical analysis was performed on the pre-intervention and post-intervention 
results. Pre- and post-intervention pain results for each participant for Subortholene 
and EVA are presented in figures 1 and 2 respectively. Mean pre- and post-
intervention FFI results for pain, disability and functional limitation, together with 
Mean FFI Scores for Subortholene and EVA are presented in Tables 1 and 2. Paired t-
test analysis scores for Subortholene Orthoses resulted in a statistically significant 
difference (p=0.002). EVA Orthoses were similarly tested, also yielding statistically 
significant results (p=0.009). 
Mean FFI score (the mean of all 3 variables added together) for Subortholene and 
EVA Orthoses resulted in the same statistical significance of p=0.001.There was a 
reduction of pain in both instances – with a pain reduction of 40.4% and 39.2% for 
Subortholene and EVA respectively. 
The other two criteria of the FFI – Disability and Functional Limitation – also 
exhibited significant improvement, with disability reduced by 24.7% and 33%, while 
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Functional Limitation scores were also reduced by 41.5% and 48.5% for Subortholene 
and EVA respectively.
An improvement in the RAI score for Subortholene Orthoses of 54% was recorded, 
with the paired t-test analysing these scores before and after intervention yielding 
p=0.001. Likewise, same statistical test for EVA Orthoses, RAI score improvement 
resulted in p=0.004. Pre- and post-intervention RAI scores are presented in Table 3.
Discussion
Although advanced hindfoot disease in RA is a difficult condition to manage, there 
have been no significant recent studies on the effectiveness of orthoses on chronic 
talocrural and subtalar joint pain, disability and functional limitation in this condition.
Most studies in fact concentrated on forefoot pain and kinematics. The lack of such 
trials has been specifically attributed to a difficulty arising from subjects’ inability to 
differentiate between subtalar and ankle joint pain [16]. In order to circumvent this 
problem, and since the subtalar and ankle joints are interdependent, with the talus 
being a common component, this study was devised to include both joints (often 
termed the ‘ankle joint complex’) so that participants did not have to differentiate 
between pain in either of the two joints which comprise the hindfoot. 
This study explores the possibility of providing an adjunct, non-pharmacological 
treatment modality for the painful ankle joint complex, which is most often affected 
in advanced disease. All participants had been on powerful immunosuppressants, 
steroids and non-steroidal anti-inflammatory drugs for the management of their 
condition. Notwithstanding this, however, they were still under considerable pain, as 
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evidenced by their FFI scores, for a mean duration of 5.7 years as determined by their 
medical history and interview. Certainly, this condition had become chronic, with 
these patients requiring another modality of treatment besides pharmacological 
management which, undeniably, carries potentially severe side effects. Since such 
prolonged drug therapy is likely to affect quality of life, a supplementary management 
modality such as orthoses would become necessary. 
A reduction in pain might mean a reduction in intake of drugs and hence reduced 
side-effects, with consequent improvement in patients’ quality of life. Furthermore, if 
drastic surgery, such as arthrodesis, can be prevented or at least delayed or the 
problem accommodated during long surgical waiting lists, orthoses would become an 
attractive option in the management of painful rheumatoid ankles.
For each intervention, pain was assessed before and after wearing the orthotic for 3 
months. There was a clear reduction of pain in both instances – with a pain reduction 
of 40.4% and 39.2% for Subor holene and EVA respectively. It can be deduced, 
however, that the pain had not disappeared completely after 3 months’ use of the 
orthoses. Their longer t rm effect, unfortunately, has not been assessed in this trial. 
Possibly 3mm subortholene and low-density EVA offered the same 
amount of control on the talo-crural joint. This was further ensured as 
both orthoses were manufactured simultaneously over the same cast, 
thus ensuring the same amount of posting applied.
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The non-coincidental effect of orthoses on pain can be further demonstrated by the 
fact that, when the first set of devices was stopped, the participants reverted back to 
their previous pain levels, which was again reduced upon the introduction of the 
second type of orthoses. 
The small sample size is a limitation of this study. However, with the strict 
inclusion/exclusion criteria, it became quite difficult to recruit the right participants 
and indeed 11 prospective participants had to be excluded for various reasons. 
Nonetheless, the highly statistically significant results attained throughout the study 
clearly demonstrate that in this case the sample size was sufficient. Nonetheless, this 
pilot study should inform the design of a larger study given the optimal results 
obtained. 
Summation of the scientific data arising out of this trial indicates that orthotic 
intervention in hindfoot pain in RA produced a significant improvement in 
participants’ pain scores, lessened disability, reduced functional limitation, reduced 
the overall FFI score and the RAI score. Notwitstanding this, however, participants’ 
pain reduction was not complete. 
These findings indicate that orthoses could be a management option that should be 
taken in consideration when RA patients present with ankle/subtalar joint pain that 
often may produce significant disability and functional limitation. 
Conclusion
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Both Subortholene and EVA orthoses significantly reduced pain, disability and 
functional limitations in participants with chronic ankle/subtalar joint pain in 
rheumatoid arthritis. Either type of orthoses should be considered as an adjunct to 
pharmacological treatment of patients with painful chronic ankle joint complex in 
RA.  
Figures legends
Figure 1: Mean pre- and post- intervention FFI Subortholene Scores
Figure 2: Mean pre- and post-intervention FFI EVA Scores
Tables:
Table 1: FFI Scores Subortholen Orthoses
Table 2: FFI Scores EVA Orthoses
Table 3: Ritchie Articular Index Scores for both types of Orthoses Pre and Post 
Intervention
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Table 1: FFI Scores Subortholen Orthoses
Pre-Intervention Post-Intervention
Mean ST Dev Mean St Dev p-value
Pain 44.36 19.94 26.94 12.08 0.009
Disability 54.10 15.19 36.06 10.72 0.001
Activity 
Limitation
19.31 12.47 9.95 6.32 0.007
FFI Score 39.27 12.47 24.19 7.89 0.001
Table 2: FFI Scores EVA Orthoses
Conditon 1subortholen
Pre
intervention
Post
intervention
Difference
(improvement)
MEAN 6.78 3.11 3.67
SD 3.46 1.90
Condition 2EVA
MEAN 6.22 4.00 2.22
SD 2.99 2.55
Table 3: Ritchie Articular Index Scores for both types of Orthoses Pre and Post Intervention
Pre-Intervention Post-Intervention
Mean ST Dev Mean St Dev p-value
Pain 44.33 15.24 25.42 11.08 0.002
Disability 51.697 18.21 33.761 10.59 0.003
Activity 
Limitation
15.98 12.15 9.35 7.46 0.024
FFI Score 37.34 11.79 22.84 8.04 0.001
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Brief Summary
What is known:
 In Rheumatoid Arthritis, involvement of the hindfoot may be up to 40%
 Chronic ankle joint complex disease causes significant pain, functional 
limitation and disability
 subtalar and ankle joints are affected in the most severe form of the disease, 
with the subtalar joint being involved approximately 5 to 7 years prior to the 
talocrural joint
What this study adds:
 Both Subortholene and EVA orthoses significantly reduced pain, disability 
and functional limitations in participants with chronic ankle/subtalar joint pain 
in rheumatoid arthritis.
 Either type of orthoses should be considered as an adjunct to pharmacological 
treatment of patients with painful chronic ankle joint complex in RA.  
 A reduction in pain might mean a reduction in intake of drugs and hence 
reduced side-effects, with consequent improvement in patients’ quality of life.
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